ArticleBriefings in bioinformatics2025
Finding coexisting combinations of posttranslational modifications with HomMTM spectra.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Posttranslational modifications (PTMs) are common biochemical processes that occur after protein synthesis, playing a pivotal role in regulating the activity, localization, stability, and interaction of proteins. Phosphorylation is one of the most crucial and widely studied PTMs, which is widely implicated in cell signal pathways and regulates many cellular processes. For peptide identification with PTMs, tools based on tandem mass spectrum have been developed. However, the existing tools report only one peptide isoform for a given query spectrum, ignoring the probability that multiple isoforms coexist in one single spectrum, which is important for analyzing how different combinations of modifications coexist and compete in cells, leading to diverse functional outcomes. In this paper, we present a workflow to find coexisting combinations of PTMs, aiming at exploring the possibility of simultaneously identifying multiple isoforms from the query spectrum. An algorithm is designed for the identification of at most two isoforms coexisting in a query spectrum. Applying our method to two real phosphopeptide datasets, U2OS and UCEC, we found that coexisting phosphopeptide isoforms occur in 2.16% of the U2OS dataset and 7.19% of the UCEE dataset. To further evaluate the performance of our algorithm for isoform identification, we develop a simulator for generating simulated spectrum with the corresponding ground-truth isoforms. Experiments on the simulated datasets show that our algorithm can achieve an isoform identification accuracy of 85.4%.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.